GlassScriptPhysician profile
Richard H Ofstein
NPI 1417138520
$7,317.65
in general payments reported to CMS, 2019-2025
26 companies · $1,199 in 2025
The $1,199 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $556 · 2020: $409 · 2021: $1,159 · 2022: $895 · 2023: $1,778 · 2024: $1,322 · 2025: $1,199.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,300.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,299.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,644.48 | 2021-2025 | Enroute Transcarotid Neuroprotection System |
| Medtronic, INC. | $1,495.57 | 2021-2025 | Abre, Mvp, Venaseal |
| Abbott Laboratories | $664.47 | 2022-2024 | Diamondback Peripheral, Jeti All In One Non-Sterile Kit, Jeti |
| Silk Road Medical, INC. | $571.85 | 2023-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Philips North America LLC | $529.33 | 2019-2024 | (6536) Phoenix |
| W. L. Gore & Associates, INC. | $451.48 | 2019-2024 | Gore Tag Thoracic Branch Endoprosthesis, Excluder Conformable Aaa Endoprosthesis With Active Control |
| Endologix LLC | $372.99 | 2021-2024 | |
| Shockwave Medical, INC | $302.75 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Penumbra, INC. | $256.58 | 2022-2024 | Penumbra System |
| Inari Medical, INC. | $201.17 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $171.32 | 2019-2022 | |
| Medtronic USA, INC. | $160.31 | 2019-2020 | |
| Bard Peripheral Vascular, INC. | $70.59 | 2019 | |
| Tactile Systems Technology INC | $63.66 | 2019-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Bolton Medical INC | $63.63 | 2024-2025 | Treo Abdominal Stent-Graft System |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $61.81 | 2023-2025 | Camzyos, Eliquis |
| Edwards Lifesciences Corporation | $46.70 | 2023 | Hemosphere |
| Lemaitre Vascular, INC. | $31.39 | 2024 | Artegraft Vascular Graft |
| Cardiovascular Systems INC. | $30.45 | 2019 | |
| Abiomed | $28.32 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $20.49 | 2023 | Brilinta |
| Smith+Nephew, INC. | $18.61 | 2019 | |
| Pfizer INC. | $17.61 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.11 | 2025 | |
| Ekos Corporation | $13.34 | 2019 | |
| Medtronic Vascular, INC. | $12.64 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Ofstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.